TY - JOUR
T1 - The Lancet women and cardiovascular disease Commission
T2 - reducing the global burden by 2030
AU - Vogel, Birgit
AU - Acevedo, Monica
AU - Appelman, Yolande
AU - Bairey Merz, C. Noel
AU - Chieffo, Alaide
AU - Figtree, Gemma A.
AU - Guerrero, Mayra
AU - Kunadian, Vijay
AU - Lam, Carolyn S.P.
AU - Maas, Angela H.E.M.
AU - Mihailidou, Anastasia S.
AU - Olszanecka, Agnieszka
AU - Poole, Jeanne E.
AU - Saldarriaga, Clara
AU - Saw, Jacqueline
AU - Zühlke, Liesl
AU - Mehran, Roxana
N1 - Publisher Copyright:
© 2021 Elsevier Ltd
PY - 2021/6/19
Y1 - 2021/6/19
N2 - Cardiovascular disease is the leading cause of death in women. Decades of grassroots campaigns have helped to raise awareness about the impact of cardiovascular disease in women, and positive changes affecting women and their health have gained momentum. Despite these efforts, there has been stagnation in the overall reduction of cardiovascular disease burden for women in the past decade. Cardiovascular disease in women remains understudied, under-recognised, underdiagnosed, and undertreated. This Commission summarises existing evidence and identifies knowledge gaps in research, prevention, treatment, and access to care for women. Recommendations from an international team of experts and leaders in the field have been generated with a clear focus to reduce the global burden of cardiovascular disease in women by 2030. This Commission represents the first effort of its kind to connect stakeholders, to ignite global awareness of sex-related and gender-related disparities in cardiovascular disease, and to provide a springboard for future research.
AB - Cardiovascular disease is the leading cause of death in women. Decades of grassroots campaigns have helped to raise awareness about the impact of cardiovascular disease in women, and positive changes affecting women and their health have gained momentum. Despite these efforts, there has been stagnation in the overall reduction of cardiovascular disease burden for women in the past decade. Cardiovascular disease in women remains understudied, under-recognised, underdiagnosed, and undertreated. This Commission summarises existing evidence and identifies knowledge gaps in research, prevention, treatment, and access to care for women. Recommendations from an international team of experts and leaders in the field have been generated with a clear focus to reduce the global burden of cardiovascular disease in women by 2030. This Commission represents the first effort of its kind to connect stakeholders, to ignite global awareness of sex-related and gender-related disparities in cardiovascular disease, and to provide a springboard for future research.
UR - http://www.scopus.com/inward/record.url?scp=85106556565&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85106556565&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(21)00684-X
DO - 10.1016/S0140-6736(21)00684-X
M3 - Review article
C2 - 34010613
AN - SCOPUS:85106556565
SN - 0140-6736
VL - 397
SP - 2385
EP - 2438
JO - The Lancet
JF - The Lancet
IS - 10292
ER -